التصنيف: angiotensin receptor blockers & neprilysin inhibitors المادة الفعالة:sacubitril+valsartan
heart failure indicated to reduce the risk of cardiovascular death and hospitalization for heart failure (hf) in patients with chronic heart failure (chf) (nyha class ii-iv) and reduced ejection fraction. recommended starting dose: 49 mg/51 mg po bid targ
